Unknown

Dataset Information

0

Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies.

ABSTRACT: The coronavirus disease 2019 (COVID-19) pandemic is caused by a novel coronavirus; the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Millions of cases and deaths to date have resulted in a global challenge for healthcare systems. COVID-19 has a high mortality rate, especially in elderly individuals with pre-existing chronic comorbidities. There are currently no effective therapeutic approaches for the prevention and treatment of COVID-19. Therefore, the identification of effective therapeutics is a necessity. Terpenes are the largest class of natural products that could serve as a source of new drugs or as prototypes for the development of effective pharmacotherapeutic agents. In the present study, we discuss the antiviral activity of these natural products and we perform simulations against the Mpro and PLpro enzymes of SARS-CoV-2. Our results strongly suggest the potential of these compounds against human coronaviruses, including SARS-CoV-2.

SUBMITTER: Diniz LRL 

PROVIDER: S-EPMC7825698 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies.

Diniz Lúcio Ricardo Leite LRL   Perez-Castillo Yunierkis Y   Elshabrawy Hatem A HA   Filho Carlos da Silva Maia Bezerra CDSMB   de Sousa Damião Pergentino DP  

Biomolecules 20210107 1

The coronavirus disease 2019 (COVID-19) pandemic is caused by a novel coronavirus; the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Millions of cases and deaths to date have resulted in a global challenge for healthcare systems. COVID-19 has a high mortality rate, especially in elderly individuals with pre-existing chronic comorbidities. There are currently no effective therapeutic approaches for the prevention and treatment of COVID-19. Therefore, the identification of effectiv  ...[more]

Similar Datasets

Unknown Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies.
| S-EPMC7561147 | biostudies-literature
Unknown Molecular modeling study of natural products as potential bioactive compounds against SARS-CoV-2.
| S-EPMC10201022 | biostudies-literature
Unknown Structure-Function Characteristics of SARS-CoV-2 Proteases and Their Potential Inhibitors from Microbial Sources.
| S-EPMC8706127 | biostudies-literature
Unknown Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds.
| S-EPMC9135652 | biostudies-literature
Unknown Phycobilins as Potent Food Bioactive Broad-Spectrum Inhibitors Against Proteases of SARS-CoV-2 and Other Coronaviruses: A Preliminary Study.
| S-EPMC8222545 | biostudies-literature
Unknown In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
| S-EPMC7504347 | biostudies-literature
Unknown Pyridine Derivatives as Potential Inhibitors for Coronavirus SARS-CoV-2: A Molecular Docking Study.
| S-EPMC10076986 | biostudies-literature
Unknown Peroxide derivatives as SARS-CoV-2 entry inhibitors.
| S-EPMC10733699 | biostudies-literature
Unknown Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors.
| S-EPMC8264305 | biostudies-literature
Unknown Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2.
| S-EPMC8200525 | biostudies-literature